Skip to content

We Walk: Impact of Exercise Dose on Health Outcomes Among Women Ages 60-75

We Walk - Energy Expenditure and Health Outcomes in Older, Sedentary Women.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01722136
Acronym
WW
Enrollment
72
Registered
2012-11-06
Start date
2012-08-31
Completion date
2015-06-30
Last updated
2019-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition

Brief summary

The overall goal is to determine whether any energy expenditure compensation in response to 16 weeks of aerobic exercise at a higher-dose is greater compared to a lower-dose intervention in older women, and to begin to investigate underlying physiological mechanisms that influence energy expenditure changes in older women.

Detailed description

The overall goal is to determine whether any energy expenditure compensation in response to 16 weeks of aerobic exercise at a higher-dose is greater compared to a lower-dose intervention in older women, and to begin to investigate underlying physiological mechanisms that influence energy expenditure changes in older women. Changes in all components of energy expenditure, as well as concentrations of plasma leptin and serum free T3, in response to the two different exercise programs (14 and 8 kcal/kg body weight weekly, 60-65% VO2max, 4 days/wk) will be compared in older, non-obese women (60-75 yrs, BMI=18-30 kg/m2). Specific Aim 1: To determine whether differential changes in total daily energy expenditure and its components occur in older women in response to two exercise programs of different doses. State-of-the-art methods will be used (total daily energy expenditure by doubly labeled water; non-exercise activity thermogenesis using Physical Activity Monitoring System; resting metabolic rate and thermic effect of food via indirect calorimetry). Primary Hypothesis: Due to a greater decline in NEAT, women will exhibit a smaller increase in total daily energy expenditure in response to the higher-dose, compared to the lower-dose, exercise program, despite greater increases in resting metabolic rate and thermic effect of food. Specific Aim 2: To explore whether differential changes occur in plasma leptin and serum free triiodo-L-thyronine (free T3) concentrations in older women in response to 16-week aerobic exercise programs of two different doses. We hypothesize that in response to the higher-dose exercise program, women will exhibit larger decreases in plasma leptin and serum free T3 concentrations, compared to the lower-dose exercise program. We will also determine whether women exhibit greater improvements in plasma lipids, insulin sensitivity (using homeostasis model assessment, HOMA, score), blood pressure, and aerobic fitness in response to the higher-dose, compared to the lower-dose, exercise program.

Interventions

BEHAVIORALLow Dosage

Exercise dose of 8kcal/kg/week

BEHAVIORALHigh Dosage

Exercise dose of 14kcal/kg/week

Sponsors

University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18-30 * Sedentary (exercising less than 20 minutes no more than 3 times per week) * Non-smoking * Weight stable (+/- 5%) over past 3 months

Exclusion criteria

* Self-reported cardiovascular disease * Additional self-reported medical conditions * Medications known to affect metabolism * Excess caffeine use * Self-reported contradictions according to ACSM * Unwillingness to provide informed consent

Design outcomes

Primary

MeasureTime frame
Change from baseline total daily energy expenditure and its components (resting metabolic rate, thermic effect of food, non-exercise activity thermogenesis)in 4 monthsBaseline (pre-intervention); 4 months (post-intervention)

Secondary

MeasureTime frame
Change from baseline plasma leptin and serum free triiodo-L-thyronine (free T3) concentrations in 4 monthsBaseline (pre-intervention); 4 month (post-intervention)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026